期刊文献+

桃红四物汤治疗不稳定型心绞痛30例的疗效观察与护理 被引量:2

暂未订购
导出
摘要 目的观察在常规抗心绞痛治疗的基础上加用桃红四物汤联合治疗不稳定型心绞痛的疗效。方法将56例患者随机分为两组。对照组26例采用硝酸甘油静脉滴注,倍他乐克、阿司匹林、奥扎格雷口服等常规抗心绞痛治疗;治疗组30例在对照组治疗的基础上加用桃红四物汤。观察两组患者在治疗4周后心绞痛的临床症状、发作频次、持续时间和血脂变化情况、硝酸甘油用量并进行比较。结果治疗组与对照组在心绞痛症状改善、发作频次、持续时间以及血脂变化、硝酸甘油用量方面有显著差异(P<0.05),治疗组优于对照组。结论在常规抗心绞痛治疗基础上加用桃红四物汤加减,可减少冠状动脉性心脏病患者的心绞痛发作频率并改善症状,临床疗效满意。
出处 《中国药业》 CAS 2011年第12期76-77,共2页 China Pharmaceuticals
  • 相关文献

参考文献3

二级参考文献28

  • 1孔繁立,兰若,尤松鑫,成启予.不稳定型心绞痛心肾阳虚证血浆性激素及自由基反应的变化[J].甘肃中医,1993,6(6):1-3. 被引量:15
  • 2刘德桓,许真真,郭伟聪.冠心病心绞痛395例中医证型特点探讨[J].中医杂志,1995,36(10):617-618. 被引量:95
  • 3张宇,许桂艳,陈玉娟,李玉莲.四逆汤口服液中附子与干姜配伍前后有效成分变化[J].佳木斯医学院学报,1996,19(3):13-15. 被引量:9
  • 4陈灏珠 主编.实用内科学(第11版)[M].北京:人民卫生出版社,2001.310.
  • 5Ambrose JA, Winters SL, Stem A, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris[J]. J Am Coll Cardiol, 1985,5:609-16.
  • 6Mulcaby R, Daly L, Graham I. Unstable angina : natural history and determinants of prognosis[J]. Am J Cardiol. 1981,48:525- 8.
  • 7卢传坚.干姜提取物对兔心脏功能和血流动力学的影响[D]..广州中医药大学博士论文集[C].,2004.56-66.
  • 8张宁 王朝晖.四逆汤药物配伍研究[J].佳木斯医学院学报,1996,18(12):9-11.
  • 9Diagnose and Treat Specification of Thoracic Obstruction Cardiodynia(coronary artery disease angina):Chinse Medicine Emergency Case Research[M].Shanghai:The Press of Shanghai College of Traditional Chinese Medicine,1989,37-45.Chinese
  • 10The suggestion of coronary artery disease denomination and diagnostic code[J].the Journal of Chinese Angiocardiopathy,1981,(1):75.Chinese

共引文献45

同被引文献32

  • 1徐浩,陈可冀.中西医结合防治冠心病研究的难点与对策[J].中国中西医结合杂志,2007,27(7):647-649. 被引量:18
  • 2陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 3GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause- specific mortality for 240 causes of death, 1990-2013 : a systematic analysis for the Global Burden of Disease Study 2013 [ J]. Lancet ,2015,385 (9963) : 117-171.
  • 4Lozano R, Naghavi M, Foreman K, et ah Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [J]. Lancet,2012,380(9859) :2095-2128.
  • 5Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial Barrier and Its Abnormalities in Cardiovascular Disease [ J ]. Front Physio1,2015, (6) :365.
  • 6Shi N, Chen SY. Smooth Muscle Cell Differentiation: Model Systems,Regulatory Mechanisms, and Vascular Diseases [ J ]. J Cell Physiol,2016,231 (4) :777-787.
  • 7Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture [ J ]. Physiol Rev ,2005,85 ( 1 ) : 1-31.
  • 8Bendeck MP,Irvin C, Reidy M, et al. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha (v) beta (3) integrin [ J ]. ArteriosclerThrombVascBiol, 2000,20 ( 6 ) : 1467-1472.
  • 9Li G,Jin R,Norris RA,et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway [ J ]. Atherosclerosis, 20 ! 0,208 ( 2 ) : 358 -365.
  • 10Conti P, Shaik-Dasthagirisaeb Y. Atherosclerosis: a chronic inflammatory disease mediated by mast cells [ J]. Cent Eur J Immunol,2015,40 (3) :380-386.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部